論文: Reuters
要約
AI is revolutionizing drug discovery and safety testing as drug developers adopt these technologies in alignment with FDA initiatives to reduce animal testing. Read this Reuters article to learn how cutting back on animal testing by using AI technology can save the pharmaceutical industry time and money.
Published: 2025年9月2日
FDAのmAbsに対する動物実験の段階的廃止に向けた準備と対策は万全ですか？
This webinar will explain how new approach methodologies (NAMs), including in silico tools and computational modeling, can be integrated into your drug development programs to align with the FDA Roadmap to phase out animal tests.
